Women's Health
What Happens to Fasting Insulin with PCOS?
Women with PCOS are two to four times more likely to have elevated fasting insulin than women without the condition, even at a healthy body weight. The relationship between PCOS and insulin isn't just about blood sugar — it's a core driver of the hormonal cascade that makes the condition so hard to manage. Understanding what's actually happening to your insulin can change how you approach treatment.
What Happens to Fasting Insulin with PCOS?
Fasting insulin is almost always elevated in PCOS, and the elevation isn't incidental — insulin resistance is a central mechanism, not a side effect. Studies estimate that 65–80% of women with PCOS have measurable insulin resistance, even those who are lean (Diamanti-Kandarakis & Dunaif, Endocrine Reviews 2012; PMID: 22947954). The main caveat: fasting insulin can look normal on standard lab panels while resistance is still present, which is why the number alone doesn't tell the whole story. Women with thin-phenotype PCOS are the clearest exception — they may have subtle insulin dysregulation that a fasting number misses entirely.
---
Why Insulin Resistance Is Central to PCOS, Not Just a Complication
The traditional framing treats elevated androgens as the root of PCOS and insulin resistance as a downstream complication. The evidence increasingly reverses that hierarchy. Hyperinsulinemia — excess circulating insulin — directly stimulates ovarian theca cells to produce more testosterone. It also suppresses sex hormone-binding globulin (SHBG) synthesis in the liver, which raises free androgen levels even when total testosterone looks borderline (Nestler et al., New England Journal of Medicine 1988; PMID: 3140954).
This creates a feedback loop. High insulin → more androgen → disrupted ovulation → more LH dominance → more androgen → worsening insulin signaling at the muscle and fat cell level. Fasting insulin is the most accessible window into that loop through routine bloodwork.
If you want a deeper look at what a normal fasting insulin reading actually means in the context of a hormonal condition, understanding what causes fasting insulin to be out of range is a useful reference for interpreting your own labs.
What the Numbers Typically Look Like
Conventional lab reference ranges flag fasting insulin above roughly 25 µIU/mL as elevated, but many functional medicine practitioners and endocrinologists use a tighter threshold of 5–10 µIU/mL as optimal. In women with PCOS, fasting insulin commonly runs between 15 and 35 µIU/mL, with obese PCOS cohorts frequently exceeding 40 µIU/mL (Legro et al., Journal of Clinical Endocrinology & Metabolism 1999; PMID: 10022420).
The HOMA-IR calculation (fasting insulin × fasting glucose ÷ 405) gives a better snapshot than fasting insulin alone. A HOMA-IR above 2.0 suggests insulin resistance; above 2.5 is common in PCOS even with normal fasting glucose. You can track fasting glucose changes over time alongside insulin — what happens to fasting glucose with PCOS-adjacent hormonal conditions gives useful context on how these two markers move together.
---
Can a Tumor Make PCOS Insulin Resistance Worse?
The secondary keyword here surfaces a real and underrecognized clinical scenario. Some women are diagnosed with PCOS but have a concurrent or underlying tumor — most commonly an adrenal adenoma, an insulinoma, or in rarer cases a prolactin-secreting pituitary tumor (prolactinoma) — that is either mimicking PCOS or substantially amplifying it.
Insulinomas are pancreatic tumors that secrete insulin autonomously. They produce episodic hypoglycemia followed by reactive hyperinsulinemia, which can look like PCOS-pattern insulin resistance on labs but follows a different clinical trajectory. An insulinoma will typically cause fasting glucose to drop below 55 mg/dL during a 72-hour fast, which distinguishes it from PCOS-related hyperinsulinemia.
Adrenal adenomas that overproduce DHEA-S or cortisol (Cushing's syndrome) can produce a PCOS-like picture: elevated androgens, anovulation, and worsening insulin resistance. Cortisol raises fasting glucose and blunts insulin signaling directly. Women who have a PCOS diagnosis but also have very high DHEA-S, central fat distribution, easy bruising, or hypertension should discuss adrenal imaging with their physician.
Prolactinomas affect insulin sensitivity indirectly. Elevated prolactin reduces dopamine tone, alters GnRH pulsatility, and can worsen the LH/FSH imbalance already present in PCOS. If your prolactin is elevated alongside PCOS markers, an MRI to rule out a pituitary adenoma is standard of care before attributing everything to PCOS (Glezer & Bronstein, Pituitary 2015; PMID: 25786730).
The practical takeaway: if your PCOS symptoms feel severe, if insulin resistance isn't responding to lifestyle change, or if other hormones (cortisol, DHEA-S, prolactin) are significantly out of range, imaging and expanded bloodwork are warranted before settling on a PCOS-only explanation. For more context on how prolactin interacts with PCOS specifically, what happens to prolactin levels with PCOS is worth reviewing.
---
Natural Remedies for Insulin Resistance in PCOS
Lifestyle interventions have the strongest evidence base and should be the foundation of any approach. The good news is that relatively modest changes move the needle meaningfully in PCOS.
Diet
Low-glycemic and lower-carbohydrate dietary patterns consistently reduce fasting insulin in PCOS cohorts. A 2012 randomized trial comparing a low-GI diet to a macronutrient-matched standard healthy diet found that women on the low-GI diet had a 30% greater improvement in insulin sensitivity after 12 months (Marsh et al., American Journal of Clinical Nutrition 2010; PMID: 20881074). Protein at 25–30% of calories, prioritizing fiber-rich carbohydrates, and limiting refined sugars and ultra-processed foods are consistent recommendations across guidelines.
Exercise
Resistance training and high-intensity interval training (HIIT) both improve insulin sensitivity in PCOS, with HIIT showing particularly robust effects on HOMA-IR. A meta-analysis of exercise interventions in PCOS found a significant reduction in fasting insulin (weighted mean difference approximately −2.0 µIU/mL) across randomized trials, with greatest effect in the exercise-plus-diet combined arms (Benham et al., Obesity Reviews 2018; PMID: 29488295).
Sleep and Stress
Cortisol dysregulation from poor sleep or chronic stress directly worsens insulin resistance. Even one week of sleep restriction to 5 hours per night in healthy adults increases fasting insulin by approximately 20% in controlled studies. In PCOS, where HPA axis dysregulation is already common, sleep hygiene and stress management are not soft lifestyle advice — they have measurable metabolic consequences.
---
Best Supplements for Insulin Resistance in PCOS
The supplement evidence in PCOS is notably stronger than in most areas of women's health, primarily because PCOS presents a large, well-defined patient population with clear biomarker endpoints.
Inositol (Myo-Inositol + D-Chiro-Inositol)
Myo-inositol (MI) and D-chiro-inositol (DCI) are the most studied supplements for insulin resistance in PCOS. They act as insulin second messengers in the signaling cascade. The most replicated finding uses a 40:1 MI:DCI ratio, approximately mirroring the physiological plasma ratio. A 2019 meta-analysis of 27 randomized controlled trials found that myo-inositol significantly reduced fasting insulin (mean reduction −2.3 µIU/mL), HOMA-IR, and testosterone in women with PCOS (Unfer et al., Gynecological Endocrinology 2017; PMID: 28906161). Standard dosing is 2–4 g myo-inositol daily.
Berberine
Berberine activates AMPK, the same energy-sensing enzyme targeted by metformin, and has been compared directly to metformin in PCOS trials. A head-to-head trial found comparable reductions in fasting insulin, HOMA-IR, and androgen levels between berberine (500 mg three times daily) and metformin (500 mg three times daily), with berberine showing a better lipid profile (Zhao et al., European Journal of Endocrinology 2012; PMID: 22019891). Berberine is considered one of the most clinically credible botanical options for insulin resistance.
Magnesium
Magnesium deficiency is highly prevalent in insulin-resistant states and in PCOS specifically. Magnesium acts as a cofactor for insulin receptor kinase activity, and low magnesium worsens receptor sensitivity. Supplementation with magnesium glycinate (a form with high bioavailability and low GI side effects) at 300–400 mg elemental magnesium daily has been shown to reduce fasting insulin and improve HOMA-IR in at-risk adults. What supplements affect fasting insulin in women covers the mechanistic detail for several of these compounds.
Omega-3 Fatty Acids
EPA and DHA reduce hepatic lipid accumulation, lower triglycerides, and reduce systemic inflammation — all of which improve the metabolic environment that drives insulin resistance. In PCOS specifically, omega-3 supplementation has been shown to reduce fasting insulin and androgen levels. Typical effective doses in trials are 2–4 g combined EPA/DHA daily.
Vitamin D
Vitamin D receptors are present on pancreatic beta cells and in skeletal muscle tissue involved in glucose uptake. Deficiency (below 20 ng/mL) is common in PCOS and correlates with worse insulin resistance. Supplementation to replete deficiency has shown modest but consistent improvements in insulin sensitivity and menstrual regularity in PCOS cohorts, though the effect is most pronounced when baseline levels are low.
---
Vitamins for Insulin Resistance: What Actually Has Evidence
Not all vitamins marketed for blood sugar support have clinical trial data. The table below separates the well-supported from the speculative.
| Vitamin / Nutrient | Mechanism | Evidence Level in PCOS | Notes |
|---|---|---|---|
| Myo-Inositol | Insulin second messenger | Strong (27 RCTs) | 40:1 MI:DCI ratio preferred |
| Magnesium Glycinate | Insulin receptor kinase cofactor | Moderate-strong | Most bioavailable form |
| Vitamin D3 | Beta-cell function, muscle glucose uptake | Moderate | Best when correcting deficiency |
| Omega-3 (EPA/DHA) | Anti-inflammatory, hepatic lipid reduction | Moderate | 2–4 g/day in trials |
| Berberine | AMPK activation (metformin-like) | Strong | Not a vitamin; botanical alkaloid |
| Chromium | Potentiates insulin receptor signaling | Weak-moderate | Small effect sizes |
| Zinc | Insulin synthesis and secretion | Weak-moderate | Often deficient in PCOS |
| B12 | Metformin co-supplementation | Supportive only | Important if on metformin |
For context on how these considerations play out in pregnancy and postpartum, where insulin dynamics shift considerably, what happens to fasting insulin in the postpartum period offers useful background.
---
What This Means for Your Formula
Personalized supplementation for PCOS-related insulin resistance isn't a generic multivitamin problem — it requires matching specific compounds to your actual lab findings, body weight, and symptom pattern. Ones addresses this directly by analyzing your bloodwork (including fasting insulin, HOMA-IR if provided, SHBG, and androgens) alongside wearable data on sleep and activity, then building a formula from clinically dosed actives.
For women whose insulin picture drives the formula, Ones draws from its catalog in targeted ways:
- Omega-3 (EPA/DHA): Included at doses matching the anti-inflammatory and insulin-sensitizing ranges used in trials — typically 2 g or more combined EPA/DHA — not the token 300 mg amounts common in generic multis.
- Magnesium Glycinate: Dosed to supply meaningful elemental magnesium (300–400 mg range), using the glycinate chelate specifically for its superior absorption and tolerability compared to magnesium oxide.
- Vitamin D3 + K2 (MK-7): Calibrated to your actual 25-OH vitamin D level, since blanket dosing ignores the fact that repletion needs differ by more than tenfold between individuals.
Berberine and myo-inositol are not currently in Ones' catalog, but the platform's AI can identify when those compounds are a strong clinical fit and flag them for discussion with a healthcare provider — a more useful output than silently substituting a weaker alternative.
---
Key Takeaways
- Elevated fasting insulin is found in 65–80% of women with PCOS, including lean phenotypes, making it one of the most consistent biomarkers in the condition.
- Fasting insulin drives the hormonal cascade — hyperinsulinemia directly stimulates androgen production and suppresses SHBG, worsening free testosterone levels.
- A normal fasting insulin number doesn't rule out insulin resistance — HOMA-IR and clinical context matter as much as the isolated value.
- Concurrent tumors (adrenal adenoma, insulinoma, prolactinoma) can amplify or mimic PCOS — imaging and expanded hormone panels are appropriate when the picture doesn't fit or doesn't respond to standard interventions.
- Myo-inositol, berberine, magnesium glycinate, omega-3s, and vitamin D have the strongest evidence for reducing fasting insulin in PCOS — but effective doses matter as much as ingredient selection.
- Lifestyle interventions (low-GI diet, resistance training, sleep optimization) remain the foundation and produce measurable HOMA-IR reductions that supplements can build on but rarely replace.
This article is for informational purposes only. Consult a qualified healthcare provider before starting any supplement protocol, especially with a hormonal condition like PCOS.